• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Sun Genomics and Dexafit Partner to Integrate Gut Health Testing

Share:

December 31, 2019

Highlights on this story:
  • Sun Genomics partners with DexaFit to integrate gut health testing to offer microbiome analysis and insights at 27 health and wellness clinics nationwide.
  • With the addition of Sun Genomics Floré testing, DexaFit is now incorporating microbiome analysis into its approach to give its clients a thorough understanding of their gut DNA or microbiome to further measure and improve their overall health and performance.

Sun Genomics today announced that it is partnering with DexaFit, the industry’s first evidence-based fitness and wellness centers, to incorporate Sun Genomics’ microbiome analysis into DexaFit’s health solutions and platforms. By working with Sun Genomics, DexaFit can now offer its customers deep microbiome analysis and insights that are the first important step for improving their gut health, which has emerged as a critical component of overall health, well-being and performance.

Sun Genomics’ Microbiome Analysis

Sun Genomics offers comprehensive microbiome analysis and customized probiotic solutions under the Floré brand that improve overall health through personalized science. Floré empowers consumers to analyze their microbiome and take precision probiotics, which results in positive changes in their microbiome. By using DNA sequencing, Floré formulates the right prebiotics and probiotics for overall health and delivers the product directly to the customer’s door.

Founded in 2011, DexaFit provides its clients with evidence-based health and wellness approach that empowers them to take a proactive (vs reactive) approach to their health. Leveraging a network of on-site and telemedicine practitioners as well as medical-grade diagnostic testing, DexaFit provides a quantifiable, an evidence-based approach to health and wellness, including access to state-of-the-art technologies that include Body Composition Analysis, Vo2max Cardio Fitness Testing, and Metabolic Health Analysis. With the addition of Sun Genomics Floré testing, DexaFit is now incorporating microbiome analysis into its approach to give its clients a thorough understanding of their gut DNA or microbiome to further measure and improve their overall health and performance.

Availability

Sun Genomics microbiome analysis is available at all of DexaFit’s clinics around the country. The comprehensive Sun Genomics’ gut health solution, Floré, incorporating microbiome analysis with personalized probiotics tailored to each personal individual microbiome is available directly at www.sungenomics.com.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“DexaFit’s commitment to giving people the exact information they need to make informed decisions on their health makes them an ideal partner for driving awareness of the enormous impact microbiome analysis has for improving health and well being,” said Neal Gidvani, chief operating officer, Sun Genomics. “We are in the middle of a revolution in which people are taking control of their lives through solutions that provide the information and insights on their behavior and health, and DexaFit is at the forefront of that movement. We are excited to work with them to make gut health an integral part of every patient’s overall health and wellness.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AI in Pharma and Biomedicine – Analysis of the Top 5 Global Drug CompaniesAI in Pharma and Biomedicine – Analysis of the Top 5 Global Drug Companies
  • Gemini Therapeutics and Disc Medicine Announce Merger AgreementGemini Therapeutics and Disc Medicine Announce Merger Agreement
  • M&A, debt dampen US healthcare risk profile, report findsM&A, debt dampen US healthcare risk profile, report finds
  • Health Tech Giant Philips Launches New Digital Pathology PlatformHealth Tech Giant Philips Launches New Digital Pathology Platform
  • Artificial Intelligence – Leading The Silent Revolution in HealthCareArtificial Intelligence – Leading The Silent Revolution in HealthCare
  • House Speaker’s Drug-Pricing bill would Save Medicare $345B, CBO saysHouse Speaker’s Drug-Pricing bill would Save Medicare $345B, CBO says
  • Cerner to Acquire AbleVets Further Expanding Strategic and Technical Expertise in U.S. Federal Health MarketCerner to Acquire AbleVets Further Expanding Strategic and Technical Expertise in U.S. Federal Health Market
  • Social Determinants Of Health Pose Challenges For Most Americans, Survey ShowsSocial Determinants Of Health Pose Challenges For Most Americans, Survey Shows

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications